[go: up one dir, main page]

FR2647015B1 - Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique - Google Patents

Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique

Info

Publication number
FR2647015B1
FR2647015B1 FR8906422A FR8906422A FR2647015B1 FR 2647015 B1 FR2647015 B1 FR 2647015B1 FR 8906422 A FR8906422 A FR 8906422A FR 8906422 A FR8906422 A FR 8906422A FR 2647015 B1 FR2647015 B1 FR 2647015B1
Authority
FR
France
Prior art keywords
cosmetics
retinoic acid
aqueous gel
human medicine
gel based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8906422A
Other languages
English (en)
Other versions
FR2647015A1 (fr
Inventor
Shroot Braham
Brzokewicz Alain
Caron Daniele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre International de Recherches Dermatologiques Galderma filed Critical Centre International de Recherches Dermatologiques Galderma
Priority to FR8906422A priority Critical patent/FR2647015B1/fr
Priority to AU56687/90A priority patent/AU5668790A/en
Priority to IT20318A priority patent/IT1241141B/it
Priority to PCT/FR1990/000343 priority patent/WO1990014082A1/fr
Publication of FR2647015A1 publication Critical patent/FR2647015A1/fr
Application granted granted Critical
Publication of FR2647015B1 publication Critical patent/FR2647015B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/738Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR8906422A 1989-05-17 1989-05-17 Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique Expired - Fee Related FR2647015B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8906422A FR2647015B1 (fr) 1989-05-17 1989-05-17 Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique
AU56687/90A AU5668790A (en) 1989-05-17 1990-05-16 Retinoic acid-based aqueous gel
IT20318A IT1241141B (it) 1989-05-17 1990-05-16 Gel acquoso a base di acido retinoico e suo nella medicina umana e nella cosmetica
PCT/FR1990/000343 WO1990014082A1 (fr) 1989-05-17 1990-05-16 Gel aqueux a base d'acide retinoique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8906422A FR2647015B1 (fr) 1989-05-17 1989-05-17 Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique

Publications (2)

Publication Number Publication Date
FR2647015A1 FR2647015A1 (fr) 1990-11-23
FR2647015B1 true FR2647015B1 (fr) 1994-05-06

Family

ID=9381712

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8906422A Expired - Fee Related FR2647015B1 (fr) 1989-05-17 1989-05-17 Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique

Country Status (4)

Country Link
AU (1) AU5668790A (fr)
FR (1) FR2647015B1 (fr)
IT (1) IT1241141B (fr)
WO (1) WO1990014082A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134163A (en) * 1989-09-01 1992-07-28 Kligman Albert M Methods of preventing and reducing the size of striae distensae lesions
LU87843A1 (fr) * 1990-11-15 1992-08-25 Cird Galderma Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
SE9300971D0 (sv) * 1993-03-24 1993-03-24 Jan Wadstein Hudvaardskomposition
AU7637296A (en) * 1995-11-14 1997-06-05 Farmarc Nederland Bv Complex of naproxen and beta-cyclodextrin
GB2307176A (en) * 1995-11-15 1997-05-21 Todd Selwyn Everest Anti-inflammatory clathrating agents for topical use
JP3940209B2 (ja) * 1996-11-14 2007-07-04 株式会社資生堂 可溶化化粧料
DE19713092A1 (de) * 1997-03-27 1998-10-01 Wacker Chemie Gmbh Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
DE19943678A1 (de) * 1999-09-13 2001-03-15 Beiersdorf Ag Wirkstoffkombinationen aus oberflächenaktiven Citronensäureestern und Einschlußverbindungen von Cyclodextrinen und Retinoiden sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
FR2848451B1 (fr) * 2002-12-17 2007-01-12 Galderma Res & Dev Procede de stabilisation chimique d'un retinoide solubilise et composition aqueuse obtenue selon le procede comprenant au moins un retinoide sous forme salifiee
EP1575557A1 (fr) * 2002-12-17 2005-09-21 Galderma Research & Development, S.N.C. Procédé de stabilisation chimique d'un retinoide solubilisé dans un solvant au moyen d'une base
EP1449514A1 (fr) * 2003-02-13 2004-08-25 Beiersdorf AG Préparations pour le soin de la peau contenant des rétinoides, des ubiquinones, et de la biotine ou de la carnitine
FI20030426L (fi) * 2003-03-24 2004-09-25 Tomi Jaervinen Syklodekstriinikompleksit
CN117384073A (zh) * 2022-07-11 2024-01-12 南京毓浠医药技术有限公司 一种维a酸醇胺类复合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
ZA879063B (en) * 1986-12-22 1989-04-26 Hoffmann La Roche Use of 13-cis retinoic acid
LU86865A1 (fr) * 1987-05-06 1989-01-19 Oreal Nouveaux retinoates d'ammonium quaternaires,leur utilisation en cosmetique et en dermopharmacie

Also Published As

Publication number Publication date
IT9020318A0 (it) 1990-05-16
IT1241141B (it) 1993-12-29
AU5668790A (en) 1990-12-18
WO1990014082A1 (fr) 1990-11-29
FR2647015A1 (fr) 1990-11-23
IT9020318A1 (it) 1991-11-16

Similar Documents

Publication Publication Date Title
FR2647015B1 (fr) Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique
BR9006960A (pt) Composicoes farmaceuticas e cosmeticas despigmentantes a base de acido cafeico
PT83934B (pt) Emplastros aperfeicoados dermicos e transdermicos multicompartimentados
BR8906488A (pt) Gel desodorante e antitranspirante
TR26606A (tr) SüLFIRIK ASIT PROSESI VE CIHAZI
FI890899A7 (fi) Ihon hoitokompositio
IT1143052B (it) Composizione a base di idrolisato di lattalbumina per il trattamento e la cura della pelle
DK295190D0 (da) Kosmetik- og hudbehandlingssammensaetninger
BE895718A (fr) Composition d'anthralines dans un ester aromatique et utilisation dans le traitement des maladies de la peau et des ongles
FI914393A7 (fi) Laite kovettumien hajottamiseksi potilaan kehossa
DK387989D0 (da) Mund- og tandplejemiddel
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
FR2618072B1 (fr) Compositions pharmaceutiques et cosmetiques a base de pyridones et d'agents antibacteriens
AU7865794A (en) A device to stop bleeding in living human and animal tissue
FR2618071B1 (fr) Compositions cosmetiques et dermatologiques a base d'extraits de chrysanthellum
FI891118A7 (fi) Ihonpuhdistus- ja hoitoaineen sekä hierontalääkeaineen levityslaite
MA21471A1 (fr) Composition de tourrage et son utilisation dans le tourrage et le post-tourrage des peaux animales .
FR2607006B1 (fr) Composition pharmaceutique a base d'euphorbia pilulifera et/ou hirta, utilisee notamment comme cicatrisant et/ou desinfectant intestinal
PT84864A (en) Disposable manicure device used in the care of the nails
FR2346018A1 (fr) Medicament a base de montmorillonite, d'acide pyroligneux et de papaine
FR2595047B1 (fr) Creme dentaire conditionnee a base de glycerine, de sorbitol et d'alpha-alumine trihydratee
DE68924337D1 (de) Gelzubereitung und nagelkosmetik.
Enright A test of time-dependent changes in human fear
GB2221155B (en) Improvements in and relating to hair care devices
IT8846105A0 (it) Elle moda e eventuale modello di utilita'

Legal Events

Date Code Title Description
ST Notification of lapse